Quan Liao
- Nephrology top 2%
- Parathyroid Disorders and Treatments 25
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 66
- Surgery top 5%
- Pancreatitis Pathology and Treatment 31
- Thyroid and Parathyroid Surgery 10
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 7
-
- Medical Imaging and Pathology Studies 7
-
- Neuroendocrine Tumor Research Advances 21
-
- Genetic Syndromes and Imprinting 11
- Cited by
- NephrologyOncologySurgery
- Journals
- Cancer Cell International (4 papers)Frontiers in Endocrinology (4 papers)Pancreas (3 papers)
- Partner nations
- ChinaGermanyUnited Kingdom
In The Last Decade
Quan Liao
128 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 90
- Nephrology 293
- Oncology 1.0k
- Surgery 659
- Cancer Research 191
- Pulmonary and Respiratory Medicine 358
Countries citing papers authored by Quan Liao
This map shows the geographic impact of Quan Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Liao more than expected).
Fields of papers citing papers by Quan Liao
This network shows the impact of papers produced by Quan Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Liao. The network helps show where Quan Liao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Quan Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 89 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 39 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 13 | |
| 14 | 2020 | 23 | |
| 15 | [Minimally invasive parathyroid surgery]. | 2015 | 37 |
| 16 | 2015 | 4 | |
| 17 | 2012 | 7 | |
| 18 | 2012 | 11 | |
| 19 | 2010 | 92 | |
| 20 | Relationship between the pancreatic fistulae and the bacterial culture of abdominal draining fluid after pancreatic operations | 2008 | 1 |
About Quan Liao
Quan Liao is a scholar working on Nephrology, Oncology and Surgery, having authored 135 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (66 papers), Pancreatitis Pathology and Treatment (31 papers), Parathyroid Disorders and Treatments (25 papers), Neuroendocrine Tumor Research Advances (21 papers), Genetic Syndromes and Imprinting (11 papers), Thyroid and Parathyroid Surgery (10 papers), Cancer Genomics and Diagnostics (7 papers) and Medical Imaging and Pathology Studies (7 papers). The work is most often cited by research in Nephrology (293 citations), Oncology (1.0k citations) and Surgery (659 citations). Quan Liao has collaborated with scholars based in China, Germany and United Kingdom. Frequent co-authors include Yupei Zhao, Ya Hu, Taiping Zhang, Menghua Dai, Qiaofei Liu, Ming Cui, Wenming Wu, Sen Yang, Lin Cong and Mengyi Wang. Their work appears in journals such as Cancer Cell International, Frontiers in Endocrinology, Pancreas, Cancer Letters and Journal of Gastrointestinal Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.